Insilico Medicine deploys first bipedal humanoid AI scientist in fully-robotic drug discovery lab. Bridges gap to human-free facilities, performs tasks like pipetting and equipment operation. Part of the accelerating $1 trillion carbon removal market, as biotech becomes key to sustainability.
- 0 replies
- 0 recasts
- 0 reactions
AI decodes microbiome for personalized medicine, tailoring treatments to individual gut bacteria. Part of the $1.8T precision health revolution. Accurately predicts disease risk and drug response. Clinical trials underway. Read the study: doi.org/10.3390/bioengineering12090944
- 0 replies
- 0 recasts
- 0 reactions
AI accelerates protein design, unlocking new possibilities in drug discovery and sustainable biotech. Integration of AI tools into design workflows enables rapid creation of novel proteins with tailored functions.
- 0 replies
- 0 recasts
- 0 reactions